Alkem Laboratories Financial Statements
Quarterly
Yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 2,192 | 2,731 | 2,800 | 2,619 | 2,484 |
| Expenses | 1,970 | 2,209 | 2,248 | 2,198 | 2,245 |
| EBITDA | 222.59 | 522.33 | 551.55 | 420.99 | 239.13 |
| EBIT | 154.08 | 451.80 | 478.72 | 343.53 | 155.99 |
| Profit Before Tax | 258.16 | 556.12 | 581.54 | 463.94 | 242.68 |
| Net Profit | 239.99 | 468.12 | 544.26 | 525.66 | 107.58 |
| Financial Ratios | |||||
| Operating Profit Margin | 10.15% | 19.12% | 19.70% | 16.07% | 9.63% |
| Net Profit Margin | 10.95% | 17.14% | 19.44% | 20.07% | 4.33% |
| Earning Per Share (Diluted) | 20.07 | 39.15 | 45.52 | 43.96 | 9.56 |
| Dividends Per Share | 5.00 | NA | 30.00 | NA | 4.00 |
